Clearbridge Health Ltd. ( (SG:1H3) ) has provided an update.
Clearbridge Health Limited has announced the receipt of a listing and quotation notice from the SGX-ST for the dealing in, listing of, and quotation for over 1.1 billion conversion shares on the Catalist Board. This development is part of the company’s ongoing efforts to issue convertible bonds, which have been in process since 2019. The approval from SGX-ST is not an indication of the merits of the proposed issue, and the company will continue to make further announcements as necessary. Shareholders and potential investors are advised to exercise caution when dealing with the company’s securities.
More about Clearbridge Health Ltd.
Clearbridge Health Limited is a healthcare company based in Singapore, focusing on providing medical services and healthcare solutions. The company operates in the healthcare industry, offering a range of services that aim to enhance patient care and improve health outcomes.
Technical Sentiment Signal: Buy
Current Market Cap: €4.36M
Find detailed analytics on 1H3 stock on TipRanks’ Stock Analysis page.